RxDoctor Payments DataLook up a doctor →

Ahmad Al-Khatib, MD

Neurology · Bentonville, ARNPI 1548273394

Payments from drug & device makers

$29,732in general payments, 2019–2025

Across 857 payments — averaging $34.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$9K
  • Biohaven Pharmaceuticals, Inc.$5K
  • Biohaven Pharmaceutical Holding Company Ltd.$4K
  • Biogen$1K
  • UCB, Inc.$868
  • Novartis$662
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)138$9,428
Biohaven Pharmaceuticals, Inc.22$5,239
Biohaven Pharmaceutical Holding Company Ltd.14$3,605
Biogen65$1,271
UCB, Inc.43$868
Novartis42$662
EMD Serono, Inc.32$608
Eisai Inc.37$600
Supernus Pharmaceuticals, Inc.73$558
Sanofi29$523
SK Life Science, Inc.30$515
Lundbeck LLC27$493
AstraZeneca24$464
Pfizer38$413
Teva Pharmaceuticals USA, Inc.20$356
Genentech USA, Inc.20$343
Amgen16$292
Bristol Myers Squibb13$264
Amneal Pharmaceuticals LLC14$241
Neurelis, Inc.10$227
Lilly USA, LLC15$226
Johnson & Johnson(2 entities)9$174
Sunovion Pharmaceuticals Inc.12$170
Tanabe Pharma America, Inc.10$165
Argenx US, Inc.7$147
CSL Behring6$143
Otsuka America Pharmaceutical, Inc.7$138
Kyowa Kirin, Inc.8$134
Upsher-smith Laboratories LLC7$118
Banner Life Sciences, LLC6$106
Grifols USA, LLC5$106
Asahi Intecc USA, Inc.1$89
Corium, LLC5$85
Zyla Life Sciences, Inc.6$79
Currax Pharmaceuticals LLC4$57
TG Therapeutics, Inc.2$53
Acorda Therapeutics, Inc4$53
Catalyst Pharmaceuticals, Inc.3$52
Axsome Therapeutics, Inc.2$51
Merz Pharmaceuticals, LLC2$48
Jazz Pharmaceuticals Inc.2$47
MDD US Operations, LLC2$44
GE HealthCare2$44
Adamas Pharmaceuticals, Inc.2$41
Azurity Pharmaceuticals, Inc.2$40
Neurocrine Biosciences, Inc.2$39
Vertical Pharmaceuticals, LLC2$33
Sandoz1$30
Advanced Respiratory, Inc1$23
Mallinckrodt Hospital Products Inc.1$23
Cycle Pharmaceuticals Inc1$21
Kedrion Biopharma, Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19
Medtronic1$18
Livanova USA, Inc.1$18
Insmed, Inc.1$18
E.r. Squibb & Sons, L.L.C.1$17
Avanir Pharmaceuticals, Inc.1$17
ANI Pharmaceuticals, Inc.1$16
Alfasigma USA, Inc.1$16

How this compares

$29,732 in reported general payments places this provider in the 80th percentile of 93 neurology providers in Arkansas.

See all neurology providers in Arkansas

Medicare billing

Part B allowed, 2024
$170,866
Medicare patients
360
Services billed
8,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →